BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32970753)

  • 1. A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity.
    Liu Q; Fang X; Tokuno S; Chung U; Chen X; Dai X; Liu X; Xu F; Wang B; Peng P
    PLoS One; 2020; 15(9):e0239695. PubMed ID: 32970753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
    Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China.
    Wang D; Yin Y; Hu C; Liu X; Zhang X; Zhou S; Jian M; Xu H; Prowle J; Hu B; Li Y; Peng Z
    Crit Care; 2020 Apr; 24(1):188. PubMed ID: 32354360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features predicting mortality risk in older patients with COVID-19.
    Zhou J; Huang L; Chen J; Yuan X; Shen Q; Dong S; Cheng B; Guo TM
    Curr Med Res Opin; 2020 Nov; 36(11):1753-1759. PubMed ID: 32945707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.
    Du RH; Liang LR; Yang CQ; Wang W; Cao TZ; Li M; Guo GY; Du J; Zheng CL; Zhu Q; Hu M; Li XY; Peng P; Shi HZ
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32269088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk Factors for Mortality in 244 Older Adults With COVID-19 in Wuhan, China: A Retrospective Study.
    Sun H; Ning R; Tao Y; Yu C; Deng X; Zhao C; Meng S; Tang F; Xu D
    J Am Geriatr Soc; 2020 Jun; 68(6):E19-E23. PubMed ID: 32383809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Nutritional Index is associated with mortality of COVID-19 patients in Wuhan, China.
    Wang R; He M; Yin W; Liao X; Wang B; Jin X; Ma Y; Yue J; Bai L; Liu D; Zhu T; Huang Z; Kang Y
    J Clin Lab Anal; 2020 Oct; 34(10):e23566. PubMed ID: 32914892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
    Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and survival analysis in critical and non-critical patients with COVID-19 in Wuhan, China: a single-center retrospective case control study.
    Tian R; Wu W; Wang C; Pang H; Zhang Z; Xu H; Luo Q; Gao P; Shi J; Li W; Qian H; Guo F; Li T; Liu Z; Wang J; Zhou X; Qin Y; Yan X; Zhang S
    Sci Rep; 2020 Oct; 10(1):17524. PubMed ID: 33067568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19.
    Chen X; Yan L; Fei Y; Zhang C
    J Clin Lab Anal; 2020 Oct; 34(10):e23467. PubMed ID: 32656888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of CT in the short-term mortality of Coronavirus Disease 2019 (COVID-19) pneumonia in nonelderly patients: A case-control study.
    Tabatabaei SMH; Rahimi H; Moghaddas F; Rajebi H
    Eur J Radiol; 2020 Nov; 132():109298. PubMed ID: 32987252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China.
    Yang J; Chen X; Deng X; Chen Z; Gong H; Yan H; Wu Q; Shi H; Lai S; Ajelli M; Viboud C; Yu PH
    Nat Commun; 2020 Oct; 11(1):5411. PubMed ID: 33110070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
    Wang D; Hu B; Hu C; Zhu F; Liu X; Zhang J; Wang B; Xiang H; Cheng Z; Xiong Y; Zhao Y; Li Y; Wang X; Peng Z
    JAMA; 2020 Mar; 323(11):1061-1069. PubMed ID: 32031570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of fatality including radiographic findings in adults with COVID-19.
    Li K; Chen D; Chen S; Feng Y; Chang C; Wang Z; Wang N; Zhen G
    Respir Res; 2020 Jun; 21(1):146. PubMed ID: 32527255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.